Spectral Medical and Vantive Announce Topline Results from Spectral's Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock

Stock Information for Spectral Medical Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Spectral Medical Inc.

Spectral Medical Announces Third Quarter 2025 Financial Results and Provides Corporate Update
Spectral Medical Sponsors Unite for Sepsis Symposium, Chicago September 8 - 9, 2025
Spectral Medical Receives US$3 Million From Vantive
Canadian Investment Regulatory Organization Trade Resumption - EDT
Canadian Investment Regulatory Organization Trading Halt - EDT
Spectral Medical Announces Second Quarter and Provides Corporate Update
Spectral Medical Inc. Announces Filing of Base Shelf Prospectus
Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.